Evidence map›Paper›PMID 30891896›Full record

ArticleInfluenza and other respiratory viruses2019

Age-specific incidence rates and risk factors for respiratory syncytial virus-associated lower respiratory tract illness in cohort children under 5 years old in the Philippines.

Fumihiko Ueno, Raita Tamaki, Mayuko Saito, Michiko Okamoto, Mariko Saito-Obata, Taro Kamigaki, Akira Suzuki, Edelwisa Segubre-Mercado, Hananiah D Aloyon, Veronica Tallo and 3 more

Abstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. CD8Nature communications · 2024
    Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fumihiko UenoDepartment of Virology, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID 0000-0002-2547-7943
Raita TamakiDepartment of Virology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Mayuko SaitoDepartment of Virology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Michiko OkamotoDepartment of Virology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Mariko Saito-ObataDepartment of Virology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Taro KamigakiDepartment of Virology, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID 0000-0002-3612-4270
Akira SuzukiDepartment of Virology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Edelwisa Segubre-MercadoResearch Institute for Tropical Medicine, Muntinlupa, Philippines.
Hananiah D AloyonResearch Institute for Tropical Medicine, Muntinlupa, Philippines.
Veronica TalloResearch Institute for Tropical Medicine, Muntinlupa, Philippines.
Socorro P LupisanResearch Institute for Tropical Medicine, Muntinlupa, Philippines.
Hitoshi OshitaniDepartment of Virology, Tohoku University Graduate School of Medicine, Sendai, Japan.
RSV Working Group in the Philippines

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRespiratory syncytial virus (RSV) is one of the main viral causes of lower respiratory tract illness (LRTI), especially in young children. RSV vaccines, including maternal and infant vaccines, are under development; however, more epidemiological studies are needed to develop effective vaccination strategies.

objectivesTo estimate detailed age-specific incidence rates and severity of RSV-associated LRTI (RSV-LRTI) using data from a community-based prospective cohort study in the Philippines. PATIENTS/

methodsCohort children who visited health facilities due to acute respiratory symptoms were identified, and nasopharyngeal swabs were collected to detect RSV. The severity of RSV-LRTI was assessed using the severity definition proposed by the World Health Organization. Risk factors for developing RSV-LRTI and contribution of SpO

resultsA total of 395 RSV episodes which occurred in children aged 2-59 months were categorised as 183 RSV-LRTI, 72 as severe RSV-LRTI and 29 as very severe RSV-LRTI. Children aged 3-5 months had the highest incidence rate of RSV-LRTI, at 207.4 per 1000 child-years (95% CI: 149.0-279.5). Younger age group, place of living and low educational level of caregivers were associated with developing RSV-LRTI. Clinical manifestations had low levels of agreement with hypoxaemia as measured by pulse oximeter.

conclusionThe highest burden of RSV was observed in young infants aged 3-5 months, whereas the burden was also high in those aged 12-20 months. Future vaccination strategies should consider the protection of older children, especially those aged one year, as well as young infants.

Indexed as

Age FactorsChild, PreschoolFemaleHospitalizationHumansIncidenceInfantLungMaleNasopharynxPhilippinesProspective StudiesRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesRespiratory Tract InfectionsRespiratory Syncytial Virus Vaccinescohort studylower respiratory tract illnesspulse oximetryrespiratory syncytial virus

Identifiers

PMID30891896
PMCPMC6586181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.